Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Phosphorus

company

About

Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$7.99M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Phosphorus provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine by making it cost-effective, accessible, and actionable for our patients. Phosphorus’s suite of clinical-grade genomics tests use next-generation sequencing (NGS) and are available to patients through healthcare providers, hospitals, and directly to consumers through its website. The Phosphorus laboratory is CLIA and CAP certified and licensed for testing in all 50 states.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$7.99M
Phosphorus has raised a total of $7.99M in funding over 2 rounds. Their latest funding was raised on Aug 13, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 13, 2020 Series Unknown $7.99M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Phosphorus is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series Unknown